Menu Back to 1st-DIA-Medical-Communication-Workshop-in-Japan

Overview

This symposium will be conducted in Japanese Language.

Click Here to View the Program in Japanese

Program Committee

  • Keiko  Tsumori
    Keiko Tsumori Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Hiroko  Ebina, MBA, RPh
    Hiroko Ebina, MBA, RPh Principal Writer I
    Proscribe KK - Part of the ENVISION PHARMA GROUP, Japan
  • Yuko  Kojima, RPh
    Yuko Kojima, RPh Director, Biometrics, Medicine Development Unit - Japan
    Eli Lilly Japan K.K., Japan
  • Miyoshi  Masuda
    Miyoshi Masuda Senior Manager, Medical Writing, Clinical Development Administration
    Astellas Pharma Inc., Japan
  • Satoru  Mogami, MSc
    Satoru Mogami, MSc Director, Medical Writing & Regulatory Submission
    Pfizer Japan Inc., Japan
  • Junichi  Nishino, MSc, RPh
    Junichi Nishino, MSc, RPh Head, RA Functions Department, Regulatory Office Japan
    Novartis Pharma K.K., Japan
  • Tomoko  Okudaira
    Tomoko Okudaira Reviewer
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Naoko  Tejima
    Naoko Tejima Senior Manager, Scientific Writing, Global Regulatory Sciences Japan
    Bristol-Myers Squibb K.K., Japan
Load More

Digital Learning Catalog

eLearning Catalog Cover
Download